337 related articles for article (PubMed ID: 17250655)
1. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
2. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Chen N; Zhen J; Reith ME
J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
[TBL] [Abstract][Full Text] [Related]
3. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
Gorentla BK; Vaughan RA
Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
[TBL] [Abstract][Full Text] [Related]
5. Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.
Zhen J; Chen N; Reith ME
Neuropharmacology; 2005 Nov; 49(6):769-79. PubMed ID: 16122767
[TBL] [Abstract][Full Text] [Related]
6. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
Chen N; Reith ME
J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
[TBL] [Abstract][Full Text] [Related]
7. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
8. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
10. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
11. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
Li LB; Cui XN; Reith MA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
[TBL] [Abstract][Full Text] [Related]
12. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
13. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2003 Jul; 46(14):2908-16. PubMed ID: 12825932
[TBL] [Abstract][Full Text] [Related]
15. Binding of cocaine-like radioligands to the dopamine transporter at 37 degrees C: effect of Na+ and substrates.
Wang LC; Cui XN; Chen N; Reith ME
J Neurosci Methods; 2003 Dec; 131(1-2):27-33. PubMed ID: 14659820
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
17. Dopamine uptake and cocaine binding mechanisms: the involvement of charged amino acids from the transmembrane domains of the human dopamine transporter.
Dar DE; Metzger TG; Vandenbergh DJ; Uhl GR
Eur J Pharmacol; 2006 May; 538(1-3):43-7. PubMed ID: 16674939
[TBL] [Abstract][Full Text] [Related]
18. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
19. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
Chen N; Trowbridge CG; Justice JB
J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
[TBL] [Abstract][Full Text] [Related]
20. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
